Ipca Laboratories

Ipca Laboratories Limited
Company typePublic
BSE: 524494
NSE: IPCALAB
IndustryPharmaceutical
Founded19 October 1949 as The Indian Pharmaceutical Combine Association Limited
FounderK.B. Mehla
Dr. N.S. Tibrawala
Headquarters
Mumbai, Maharashtra, India[1]
Area served
Worldwide
Key people
Premchand Godha (MD)[2]
AK Jain (JMD)[3]
ProductsPharmaceutical drugs, generic drugs, antiviral drugs, over-the-counter drugs, vaccines,
RevenueIncrease ₹5,896 crore (US$710 million) (FY22)[4]
Decrease ₹884 crore (US$110 million) (FY22)[4]
Number of employees
12000 (2015)
SubsidiariesCCPL Software,[2] Ipca Traditional Remedies[5]
Websitewww.ipca.com

Ipca Laboratories Limited is an Indian multinational pharmaceutical company based in Mumbai. It produces theobromine, acetylthiophene, and p-bromotoluene as active pharmaceutical ingredients (APIs). Ipca sells these APIs and their intermediates globally.[6] It produces more than 150 formulations that include oral liquids, tablets, dry powders, and capsules.[7]

  1. ^ "Ipca Laboratories Ltd. :: Contact Us :: India Offices". Ipcalabs.com. Archived from the original on 13 November 2010. Retrieved 1 December 2010.
  2. ^ a b "Ipca Laboratories targets Rs 425cr turnover this year". Expressindia.com. 15 September 2000. Retrieved 2 December 2010.
  3. ^ "Pawan Kothari". Expresspharmaonline.com. 31 August 2010. Retrieved 2 December 2010.
  4. ^ a b "Ipca Labs Q4 net profit declines 19% at Rs 130 crore on higher expenses". Business Standard. 24 May 2022. Retrieved 3 February 2023.
  5. ^ "Ipca Laboratories Ltd plans to diversify into Ayurveda business". AyurvedNews.com. Archived from the original on 7 July 2011. Retrieved 2 December 2010.
  6. ^ "Ipca Laboratories". Business.mapsofindia.com. Retrieved 1 December 2010.
  7. ^ "Interview of Mr. AK Jain, Executive Director, Ipca Laboratories Ltd". Indiainfoline.com. Retrieved 1 December 2010.